Sanofi SA (SNY)
NASDAQ:SNY
Pcv21 Vaccine, Varivax Vaccine, Vaxelis Vaccine, Hepatitis A Vaccine, 20Vpcv Licensed Vaccine, Rotavirus Vaccine, Measles Mumps And Rubella Vaccine
Healthy Volunteers, Pneumococcal Immunization
Phase III
Recruiting
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Jan 15, 2026
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sanofi SA (SNY) have in its pipeline
SNY is currently developing the following drugs: Itepekimab, Regn3500, Pcv21 Vaccine, Varivax Vaccine, Vaxelis Vaccine, Hepatitis A Vaccine, 20Vpcv Licensed Vaccine, Rotavirus Vaccine, Measles Mumps And Rubella Vaccine, Frexalimab, Mri Contrast-Enhancing Preparations. These drug candidates are in various stages of clinical development as the company works toward FDA approval.